Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2003
10/16/2003WO2002057495A3 A modeling framework for predicting the number, type, and distribution of crossovers in directed evolution experiments
10/16/2003WO2002057430A3 Pluripotent adult stem cells derived from regenerative tissue
10/16/2003WO2002054064A3 Method for screening for progesterone receptor isoform-specific ligands
10/16/2003WO2002044384A3 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
10/16/2003WO2002038588A3 Putrescine-n-methyltransferase promoter
10/16/2003WO2002029074A3 Genetic immunisation against cervical carcinoma
10/16/2003WO2001088148A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/16/2003US20030196218 Improving existing lines of plants and development of new lines having desired traits by making a specific alteration of a specific pre-existing gene of a plant
10/16/2003US20030196217 Desaturase genes, enzymes encoded thereby, and uses thereof
10/16/2003US20030195347 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195346 An isolated amino acid sequences are expressed by a cell; for use as human secreted proteins such as human insulin, interferon, Factor VIII, human growth hormones
10/16/2003US20030195345 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195344 A DNA libraries having the vector sequences for coding the membrane receptor proteins, or fusion proteins, for binding the membrane-bound proteins; drug delivery target to specific cell site
10/16/2003US20030195338 Concatameric immunoadhesion
10/16/2003US20030195337 UL16 binding protein 4
10/16/2003US20030195334 Cell culturing and expressing the protein, chimeric polypeptides, fusion proteins; membrane protein receptor is used to bind the protein drugs thrombolytic agents, interferons, interleukins, erythropoietins
10/16/2003US20030195333 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195248 Novel approach to anti-microbial host defense with molecular shields with lipoxin compounds
10/16/2003US20030195163 Fibronectins; drug screening; treating cardiovascular/nervous system disorders
10/16/2003US20030195148 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195147 Identification of molecular structures, especially peptides, which are capable of acting at either insulin or insulin-like growth factor receptors as agonists or antagonists; treatment of diabetes
10/16/2003US20030194805 Using a culture medium that has a proliferating and activity-retaining action on animal cells, and a killing and/or multiplication- inhibition action on bacteria
10/16/2003US20030194804 For enhancing T cell response to tumour cells
10/16/2003US20030194803 Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance
10/16/2003US20030194802 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
10/16/2003US20030194800 For immunization, generation of packaging cell lines, and production of immunogenic compositions
10/16/2003US20030194798 For diagnositic, therapeutic, research, and drug discovery applications
10/16/2003US20030194794 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194793 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194792 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194791 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194790 DNA sequences coding for ester-group-cleaving enzymes
10/16/2003US20030194779 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194778 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194777 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194776 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194775 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194774 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194773 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194772 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194771 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194770 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194769 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194768 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194767 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194766 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194765 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194763 End selection in directed evolution
10/16/2003US20030194761 Novel nucleic acid sequences encoding human fibroblast growth factor-like polypeptides
10/16/2003US20030194760 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194744 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194732 For treating neoplastic diseases by testing responsiveness to interferons
10/16/2003US20030194728 Description of genetic variants of the Solute Carrier Family 26, Member 2 (SLC26A2) gene
10/16/2003US20030194727 Screening nucleic acids that encode different artificial, chimeric proteins to identify a chimeric protein that alters a phenotypic trait of a cell or organism
10/16/2003US20030194726 Thermus oshimai nucleic acid polymerases
10/16/2003US20030194720 Human ion channels
10/16/2003US20030194694 Pure recombinant influenza virus comprising a mutant ion channel protein which lacks or has reduced activity relative to the wild-type
10/16/2003US20030194408 Antibody which specifically binds to at least two variants of an epitope of an HIV-1 Tat protein
10/16/2003US20030194406 P-cadherin as a target for anti-cancer therapy
10/16/2003US20030194404 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders
10/16/2003US20030194397 Introducing platelet-rich plasma into and around the site of the injury
10/16/2003US20030194396 Antisense oligonucleotide that hybridizes iwth and inhibits the expression of human pituitary tumor-transforming gene
10/16/2003US20030194395 Th1 cell adoptive immunotherapy
10/16/2003US20030194392 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
10/16/2003US20030194391 Vaccine
10/16/2003CA2483769A1 Identification and characterization of an anthocyanin mutant (ant1) in tomato
10/16/2003CA2481953A1 Method of culturing liver cells over long time
10/16/2003CA2481437A1 Motif-grafted hybrid polypeptides and uses thereof
10/16/2003CA2481090A1 Novel pancortin-pablo protein interactions and methods of use thereof
10/16/2003CA2480802A1 A method for selecting cell lines to be used for nuclear transfer in mammalian species
10/16/2003CA2479927A1 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
10/16/2003CA2479840A1 Redifferentiated cells for repairing cartilage defects
10/16/2003CA2478932A1 Large scale methods of producing adenovirus and adenovirus seed stocks
10/16/2003CA2478930A1 Epitope constructs comprising antigen presenting cell targeting mechanisms
10/15/2003EP1353180A2 Labelling and selection of molecules
10/15/2003EP1352960A1 Antiviral therapy on the basis of RNA interference
10/15/2003EP1352955A2 HLA matching donor-originating activated lymphocytes to be used in prevention/treatment of tumors, infectious diseases and autoimmune diseases, treatment method achieved by using the lymphocytes, formula having the lymphocytes as a main constitutuent thereof, method for manufacturing the formula and preparation kit to be used to prepare the formula
10/15/2003EP1352954A2 Method of preparing culture support factor from insects
10/15/2003EP1352092A2 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
10/15/2003EP1352077A2 Materials and methods relating to protein aggregation in neurodegenerative disease
10/15/2003EP1352075A2 Maize yellow stripe1 and related genes
10/15/2003EP1352072A2 Nucleic acid delivery formulations
10/15/2003EP1352068A2 Bacillus thuringiensis insecticidal proteins
10/15/2003EP1352063A2 Receptor nucleic acids and polypeptides
10/15/2003EP1352062A2 Improved growth hormone molecules
10/15/2003EP1352057A2 Lipolytic enzyme variant
10/15/2003EP1352056A2 Polypeptides
10/15/2003EP1352054A2 Aspergillus ochraceus 11 alpha hydrolase and oxidoreductase
10/15/2003EP1352053A2 Method for processing dendritic cells and for activating macrophages with ru 41740
10/15/2003EP1352052A1 Ancillary composition for the preparation of committed mature dentritic cells
10/15/2003EP1352051A2 In vivo animal model of human leukemia
10/15/2003EP1351985A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
10/15/2003EP1351983A2 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof
10/15/2003EP1351979A1 Regulated activation of cell-membrane receptors by metal-chelating agonists
10/15/2003EP1351974A2 Using viruses to detect or purify proteins
10/15/2003EP1351970A2 Compositions and methods for the release of nucleic acid molecules from solid matrices
10/15/2003EP1351969A1 Method for generating immortal dendritic cell lines
10/15/2003EP1351968A1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
10/15/2003EP1351967A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/15/2003EP1351711A2 Generation and/or reduction of new lung tissue in an affected lung, by modulation of the wnt-pathway
1 ... 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 ... 1827